Avidity Biosciences
RNAM
#1873
Rank
A$15.79 B
Marketcap
A$102.25
Share price
0.00%
Change (1 day)
33.94%
Change (1 year)

Market capitalization of Avidity Biosciences (RNAM)

Last known market cap: A$15.79 Billion

As of September 2026 Avidity Biosciences has a market cap of A$15.79 Billion. This makes Avidity Biosciences the world's 1873th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences in 2026

End of year Market Cap

Year Marketcap Change
2026A$15.79 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
A$221.37 B 1,301.47%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$141.23 B 794.12%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
A$2.98 B-81.12%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
A$7.66 B-51.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
A$0.42 B-97.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
A$1.15 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
A$15.35 B-2.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
A$5.41 B-65.73%๐Ÿ‡บ๐Ÿ‡ธ USA